The repression sensitivity to azelastine in ARF1-deficient CRC cells was markedly restored when either wild-type ARF1 or ARF1-C159G were re-overexpressed to a level comparable to parental cells (Figure 6G). Here, ARF1 is linked to colorectal carcinoma.